PharmaShots | Incisive News in 3 Shots

Subscribe Now

Fragile X Syndrome

PharmaShots Interview: Tetra Therapeutics' Mark Gurney Shares Insight on Topline Results of BPN14770 for Fragile X Syndrome

PharmaShots Interview: Tetra Therapeutics' Mark Gurney Shares Insight on Topline Results of BPN14770 for Fragile X Syndrome

March 1, 2021

Tetra Therapeutics Reports Positive Results of BPN14770 in P-II Study for Fragile X Syndrome

Tetra Therapeutics Reports Positive Results of BPN14770 in P-II Study for Fragile X Syndrome

November 3, 2020

Asuragen's AmplideX Fragile X Dx and Carrier Screen Kit Receives the US FDA's Approval for Detecting Fragile X Syndrome (FXS)

Asuragen's AmplideX Fragile X Dx and Carrier Screen Kit Receives the US FDA's Approval for Detecting Fragile X Syndrome (FXS)

February 24, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us